ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Hyperglycemia"

  • 2022 American Transplant Congress

    Epidemiology of Post Transplant Diabetes Mellitus

    S. Al Rasbi, I. Salmi

    Renal Medicine Department, The Royal Hospital, Bausher, Oman

    *Purpose: Diabetes mellitus (DM) is a common non-communicable disease and have serious metabolic complications that contribute to death, major cardiovascular events, organs failure, and increased…
  • 2022 American Transplant Congress

    Sodium-Glucose Co-Transporter 2 Inhibitors; Short-Term Outcome in Diabetic Kidney Transplant Recipients

    J. Yagan1, T. S. Mahmoud1, A. Hasan2, O. Gheith1, n. El-Serwy1, S. Rida1, M. Mostafa1, M. Shaker1, P. Nair1, T. Alotaibi1

    1Nephrology, Hamed Al-Essa Organ Transplant Center, Kuwait, Kuwait, 2Immunometabolism, Dasman Diabetes Center, Kuwait, Kuwait

    *Purpose: The idea of using SGLT2i in kidney transplant recipients (KTR) is a legitimate one after the recent encouraging data for their use in other…
  • 2022 American Transplant Congress

    Outcomes of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Diabetic Kidney Transplant Recipients

    T. S. Mahmoud1, J. Yagan1, A. Hasan2, O. Gheith1, M. Mostafa1, S. Rida1, N. El-Serwy1, M. Shaker1, M. Khalid1, P. Nair1, T. Alotaibi1

    1Nephrology, Organ Transplant Center, Kuwait, Kuwait, 2Immunometabolism, Dasman Diabetes Center, Kuwait, Kuwait

    *Purpose: The impact of the new glucose lowering therapies, sodium-glucose cotransporter 2 inhibitors (SGLT2i) and Glucagon-like peptide-1 receptor agonists (GLP-1RA), on managing patients with type…
  • 2022 American Transplant Congress

    Safety and Efficacy of GLP-1 Agonists in Solid Organ Transplant Recipients

    E. Heiman, D. Blanco, A. Webb

    Pharmacy, Tampa General Hospital, Tampa, FL

    *Purpose: Glucagon-like peptide-1 receptor agonists (GLP-1 RA) have been shown to improve glycemic control, obesity, and cardiovascular disease in the general population. The safety and…
  • 2022 American Transplant Congress

    Impact of a Pharmacy-Led Post-Transplant Diabetes Mellitus Clinic in Solid Organ Transplant Recipients

    H. Sweiss1, R. Hall1, M. Flores2, S. Bhayana1, R. Patel1, C. Long2

    1University Health - University Hospital, San Antonio, TX, 2College of Pharmacy, University of Incarnate Word, San Antonio, TX

    *Purpose: To evaluate the impact of a pharmacy-led post-transplant diabetes mellitus (DM) clinic.*Methods: This retrospective chart review from 08/01/20 to 6/30/21 evaluated adult kidney transplant…
  • 2021 American Transplant Congress

    Transgenic Beta-cell Cxcl12 Expression and Stem Cell Mobilization Synergize to Suppress Type 1 Diabetes

    D. A. Alagpulinsa, A. Jajoo, M. H. Chapin II, M. C. Poznansky

    Vaccine & Immunotherapy Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA

    *Purpose: Hematopoietic stem and progenitor cells (HSPCs) and regulatory T cells (Tregs) highly express CXCR4, the receptor for the CXCL12 chemokine. This keeps them predominantly…
  • 2021 American Transplant Congress

    Extracellular Vesicles from Patients with Diabetic Nephropathy Induce Endothelial Dysfunction Through Icam-1 and Vcam-1 in an In Vitro Model

    E. Montagud-Marrahi1, S. Torramadé-Moix2, M. Ramirez-Bajo3, J. Rovira3, E. Bañón-Maneus3, E. Hermida1, F. Diekmann1, M. Palomo4, M. Díaz-Ricart2, P. Ventura-Aguiar1

    1Nephrology and Kidney Transplantation Department, Hospital Clínic de Barcelona, Barcelona, Spain, 2Hematopathology Department, Hospital Clínic de Barcelona, Barcelona, Spain, 3Nephrology and Transplant Experimental Laboratory (LENIT), Hospital Clínic de Barcelona, Barcelona, Spain, 4Josep Carreras Leukaemia Research Institute, Hospital Clínic de Barcelona, Barcelona, Spain

    *Purpose: Extracellular Vesicles (EVs) are membranous structures produced by cells which contain different cytoplasmic compounds and that have been described as potentially pathogenic elements in…
  • 2021 American Transplant Congress

    Relationship Between Diabetes Mellitus and Covid-19 Prognosis in Kidney Transplant Patients

    D. D. de Lucena, I. A. de Brito, M. P. Cristelli, J. O. Medina-Pestana, H. Tedesco-Silva, É. B. Rangel

    Department of Medicine, Division of Nephrology, Federal University of São Paulo, São Paulo, Brazil

    *Purpose: A high number of comorbidities associated with the severity of the disease caused by SARS-CoV-2 (COVID-19) has been reported, such as systemic arterial hypertension…
  • 2021 American Transplant Congress

    Effect of Insulin versus Oral Agents on Early Glycemic Control Following Kidney Transplant

    A. Petrosan, A. Santeusanio, R. Khaim, V. Delaney

    Mount Sinai Hospital, New York, NY

    *Purpose: Insulin therapy is commonly prescribed to treat hyperglycemia early post-kidney transplant (KTx) due to its widespread availability and ease of titration. Alternatively, there is…
  • 2021 American Transplant Congress

    The Impact of Diabetes on Young Transplant Recipients: An American Perspective

    J. M. Loera, S. C. Barrett, T. S. Zhang, A. A. Awan, B. V. Murthy, R. T. Cotton, C. A. O'Mahany, N. T. Galvan, J. A. Goss, A. A. Rana

    Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX

    *Purpose: Our study aims to demonstrate the impact of diabetes, types I and II, on American young adults (18-40 years old) requiring kidney transplantation.*Methods: Using…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 7
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences